RetractedArticleDrug design, development and therapy2015

A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.

Yonghong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.